اثر آنتی اکسیدانت کارودیلول و آلوپورینول در بیماران دیابت تیپ 2

لاریجانی, باقر ، افشاری, مژگان ، مجتهدی, علیرضا ، آستانه ای, فاطمه ، حسینی نژاد, آرش ، حشمت, رامین ، رضایی, علی ، زمانی, محمد جعفر ، مصطفی لو, سارا ، عبدالهی, محمد (1384) اثر آنتی اکسیدانت کارودیلول و آلوپورینول در بیماران دیابت تیپ 2. در: 65th Scientific Sessions (2005) American Diabetes Association, June 10-14 , 2005, San Diego, California - USA.

پیش نمایش
پیش نمایش

آدرس اینترنتی رسمی : http://professional.diabetes.org/meeting/scientifi...

عنوان انگليسي

Antioxidant effects of carvedilol and alluporinol in patients with diabetes type 2; a randomized, double-blind placebo-controlled clinical trial

خلاصه انگلیسی

Antioxidant Effects of Carvedilol and Alluporinol in Patients with Diabetes Type II; A Randomized, Double-Blind Placebo-Controlled Clinical Trial [bold]Background[/bold]: Diabe [bold]Background[/bold]: Diabetes type II is associated with oxidative stress while Carvedilol and Allopurinol has been shown to have antioxidant properties, which are thought to account for the protective effects. Objective of this study was to compare the short-term effects of Carvedilol, Allopurinol and placebo on oxidative stress status in patients with diabetes type II. [br][bold]Material and methods:[/bold] Eighty one patients were randomly assigned to four different groups: Carvedilol (6.25 mg TDS, n=20), placebo (n=20) and Allopurinol (100 mg TDS, n=20), placebo (n=21).The patients were received their treatment for two weeks. Fasting blood sugar (FBS), HbA[sub]1[/sub]c, total antioxidant capacity (FRAP test) and lipid peroxidation (TBARS assay) in plasma and saliva were measured before and after treatment.[br][bold]Results:[/bold] No significant differences in oxidative stress status, FBS and HbA[sub]1C[/sub] were seen among placebo and Carvedilol groups[bold], [/bold]and also in HbA[sub]1C[/sub] and FBS levels between Allopurinol and placebo group.[br][bold]Conclusion: [/bold]It is concluded that Allopurinol and Carvedilol are not more effective than placebo in reduction of oxidative stress in diabetic patients. However, to elaborate the exact role of Allopurinol and Carvedilol in diabetes, further large randomized clinical trials with longer time are needed. The same trend of changes in blood and saliva shown for oxidative stress indices was interesting and suggests a chance for saliva to be valuable in diagnosis of oxidative stress. BAGHER LARIJANI, MOJGAN AFSHARI, ALIREZA MOJTAHEDI, FATEMEH ASTANEHI-ASGHARI, ARASH HOSSEIN-NEZHAD, RAMIN HESHMAT, ALI REZAIE, MOHAMMAD JAFAR ZAMANI, SARA MOSTAFALOU, MOHAMMAD ABDOLLAHI 2132-PO Tehran, Islamic Republic of Iran Clinical Therapeutics/New Technology - Pharmacologic Treatment of Diabetes or its Complications

نوع سند :موضوع کنفرانس یا کارگاه (پوستر )
زبان سند : انگلیسی
نویسنده اول :باقر لاریجانی
نویسنده :سارا مصطفی لو
کلید واژه ها (انگلیسی):Diabetes, antioxidant, clinical trial
موضوعات :QV فارماکولوژی > QV 600 سم شناسی
QV فارماکولوژی
بخش های دانشگاهی :دانشکده داروسازی > بخش سم شناسی
کد شناسایی :8078
ارائه شده توسط : دکتر سارا مصطفی لو
ارائه شده در تاریخ :06 آذر 1395 06:50
آخرین تغییر :06 آذر 1395 06:50

فقط پرسنل کتابخانه صفحه کنترل اسناد

Document Downloads

More statistics for this item...